SCHEMBL23514360

SCHEMBL23514360

Cc1ncc(-c2cccc(Cl)c2)cc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
HTT P42858 2/20 0.47
STAT3 P40763 1/20 0.47
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ENPP2 Q13822 1/20 0.45
MCL1 Q07820 1/20 0.44
DHFR P00374 1/20 0.44
PPIA P62937 1/20 0.44
GRM5 P41594 1/20 0.43
MAP4K4 O95819 1/20 0.43
RAB9A P51151 1/20 0.42
PTGER1 P34995 6/20 0.42
CYP2C9 P11712 2/20 0.42
FYN P06241 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30345720 0.86 DHFR (0.48) ENPP2DHFRPPIAMAP4K4PTGER1
SCHEMBL23501727 0.86 DHFR (0.48) ENPP2DHFRPPIAMAP4K4PTGER1
SCHEMBL22239416 0.80 FYN (0.56) SMN1; SMN2MAPTLMNAMAP4K4RAB9A
SCHEMBL23501775 0.79 MAP4K4 (0.49) MCL1PPIAMAP4K4PTGER1CYP2C9
SCHEMBL7489944 0.77 DHFR (0.49) MAPTL3MBTL1KDM4EHPGDMAPK1
SCHEMBL23501776 0.76 KMT2A (0.47) SMN1; SMN2MAPTLMNAKDM4EHPGD
SCHEMBL34467306 0.75 EGLN1 (0.58) MAPTL3MBTL1KDM4E
SCHEMBL23501771 0.75 EGLN1 (0.58) MAPTL3MBTL1KDM4E
SCHEMBL23319645 0.74 ESR2 (0.54) SMN1; SMN2MAPTLMNAMAP4K4RAB9A
SCHEMBL16926498 0.73 GCK (0.55) SMN1; SMN2HTTSTAT3MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021117767-A1 METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROARYLCARBOXAMIDE ACETIC ACID DERIVATIVE 田辺三菱製薬株式会社 2021-06-17 WO disclosed